Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02617472 · ClinicalTrials.gov registry record · NA

Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI)

A NA study of Stress Urinary Incontinence and Sexual Dysfunction, sponsored by Lelo.

Completed
Registry status
NA
Development phase
93
Enrollment target
1
Study location

NCT02617472 is a NA study of Stress Urinary Incontinence and Sexual Dysfunction that has completed, run by Lelo. The registered enrollment target is 93 participants, below the 160-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02617472, a NA study of Stress Urinary Incontinence and Sexual Dysfunction, has completed, sponsored by Lelo.

COMPLETED
Registry status
NA
Development phase
93 participants
Enrollment target
1
Study location

Study Summary

This study will assess the effectiveness of a new pelvic floor exercise device in strengthening pelvic floor muscles and treating urinary incontinence among women who are experiencing symptoms of pelvic floor weakness. The study will be conducted over 12 weeks and results will be collected through self-assessment questionnaires and clinical pelvic examination. Effectiveness outcomes will be tracked over the duration of the trial and measured against historical symptoms.

Interventions

  • DEVICE Pelvic floor exerciser

Study Locations (1)

Arizona

  • Banner University Medical Center - Phoenix

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2015-11
Est. Completion 2017-08
Phase NA

Sponsor

Lelo

1 total trials

What the Registry Record Tells You About NCT02617472

The ClinicalTrials.gov registry entry for NCT02617472 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 160-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (42% lower). The listed sponsor is Lelo, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Pelvic floor exerciser is the first listed.

NCT02617472 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT02617472 about?

NCT02617472 is a clinical study titled "Effectiveness of Kegel Exercise Device in Strengthening Pelvic Floor and Treating Urinary Incontinence (UI)". This study will assess the effectiveness of a new pelvic floor exercise device in strengthening pelvic floor muscles and treating urinary incontinence among women who are experiencing symptoms of pelvic floor weakness. The study will be conducted over 12 weeks and results will be collected through s...

What is the current status of trial NCT02617472?

This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2015-11. Estimated completion is 2017-08.

What conditions does trial NCT02617472 study?

This clinical trial studies the following conditions: Stress Urinary Incontinence, Sexual Dysfunction.

What interventions are being tested in trial NCT02617472?

The interventions under investigation include: Pelvic floor exerciser (DEVICE).

Who is sponsoring clinical trial NCT02617472?

This trial is sponsored by Lelo, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02617472 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.